KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Shares Repurchased (2016 - 2025)

Merck (MRK) has disclosed Shares Repurchased for 15 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • Quarterly Shares Repurchased rose 156.03% to $1.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 billion through Dec 2025, up 289.28% year-over-year, with the annual reading at $5.1 billion for FY2025, 289.28% up from the prior year.
  • Shares Repurchased for Q4 2025 was $1.3 billion at Merck, down from $1.3 billion in the prior quarter.
  • The five-year high for Shares Repurchased was $1.3 billion in Q2 2025, with the low at $18.0 million in Q4 2021.
  • Average Shares Repurchased over 4 years is $571.7 million, with a median of $444.0 million recorded in 2024.
  • The sharpest move saw Shares Repurchased decreased 25.74% in 2024, then soared 854.1% in 2025.
  • Over 4 years, Shares Repurchased stood at $18.0 million in 2021, then skyrocketed by 2083.33% to $393.0 million in 2023, then rose by 24.43% to $489.0 million in 2024, then skyrocketed by 156.03% to $1.3 billion in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $1.3 billion, $1.3 billion, and $1.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.